Skip to main content

Peer Review reports

From: Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study

Original Submission
24 Nov 2020 Submitted Original manuscript
15 Jan 2021 Author responded Author comments - David Slade
Resubmission - Version 2
15 Jan 2021 Submitted Manuscript version 2
10 Mar 2021 Reviewed Reviewer Report
29 Mar 2021 Reviewed Reviewer Report
28 May 2021 Author responded Author comments - David Slade
Resubmission - Version 3
28 May 2021 Submitted Manuscript version 3
20 Jun 2021 Reviewed Reviewer Report
6 Jul 2021 Author responded Author comments - David Slade
Resubmission - Version 4
6 Jul 2021 Submitted Manuscript version 4
Publishing
16 Jul 2021 Editorially accepted
31 Jul 2021 Article published 10.1186/s12890-021-01612-5

You can find further information about peer review here.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us